In cancer cachexia trials, measures of physical function are commonly used as endpoints.
For drug trials to obtain regulatory approval, efficacy in physical function endpoints may be …

Cancers are among the leading causes of morbidity and mortality worldwide, and the
number of new cases is expected to rise significantly over the next decades. At the same …

One of the challenges during chemotherapy and radiotherapy is to complete the planned
cycles and doses without dose-limiting toxicity. Growing evidence clearly demonstrates the …

Chemotherapy side effects (CSE) have a strong impact on patients' quality of life (QOL). To
assess patient perceptions of CSE, their impact on QOL and doctor–patient communication …

Objective We tested the effect of dietary advice dedicated to increase intake in older patients
at risk for malnutrition during chemotherapy, versus usual care, on one-year mortality …

Background Weight loss is frequent in patients with gastrointestinal (GI) cancer. Nutritional
status deteriorates throughout anti-cancer treatment, mostly after major surgery, increasing …

Purpose Nutrition and immunity significantly affect the progression of cancer in cancer
patients. Therefore, the evaluation of the nutritional and immune status would be useful as a …

Background This study aimed to evaluate the prognostic impact of nutritional and
inflammatory measures (controlling nutritional status (CONUT) score, prognostic nutritional …

There is no consensus on the optimal endpoint (s) in cancer cachexia trials. Endpoint
variation is an obstacle when comparing interventions and their clinical value. The aim of …

People receiving cancer treatment are at nutritional risk. Their eating problems can lead to
malnutrition and weight loss. Involuntary weight loss is also a defining characteristic of tumor …